ArticleIEEE transactions on medical imaging2019
Dynamic Hyper-Graph Inference Framework for Computer-Assisted Diagnosis of Neurodegenerative Diseases.
Article in IEEE transactions on medical imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A parallel attention-augmented bilinear network for early magnetic resonance imaging-based diagnosis of Alzheimer's disease.Human brain mapping · 2022Article
- Patterns of structure-function association in normal aging and in Alzheimer's disease: Screening for mild cognitive impairment and dementia with ML regression and classification models.Frontiers in aging neuroscience · 2022Article
- Long range early diagnosis of Alzheimer's disease using longitudinal MR imaging data.Medical image analysis · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hyper-graph techniques have been widely investigated in computer vision and medical imaging applications, showing superior performance for modeling complex subject-wise relationships and sufficient flexibility to deal with missing data from multi-modal neuroimaging data. Existing hyper-graph methods, however, are inadequate for two reasons. First, representations are generated only from the observed imaging data, a process that is completely independent of the subsequent data label inference/ classification step. Thus, hyper-graph results constructed in this way may not be consistent with phenotype data such as clinical labels or scores. More critically, it might generate sub-optimal predictions in relation to clinical labels/scores. Second, current hyper-graph inference methods rely on two sequential steps: 1) building the hyper-graph for each individual modality and then predicted latent labels for new subjects upon each constructed hyper-graph and 2) a voting procedure to incorporate inference results across different hyper-graphs. This approach, however, is limited by failing to consider the complex and complementary relationships of multi-modal imaging data with respect to hyper-graph inference procedure. To address these two issues, we propose a novel dynamic hyper-graph inference method supported by a semi-supervised framework. Our method iteratively estimates and adjusts the hyper-graph structures from multi-modal imaging data until consistency between the learned hyper-graph and the observed clinical labels and scores is achieved. This hyper-graph inference framework also eases the integration process of classification (identifying individuals having neurodegenerative disease) and regression (predicting the clinical scores) within the same framework. The experimental results on identifying mild cognition impairment (MCI) subjects and the fine grained recognition of MCI progression stages show improved performance using our proposed hyper-graph inference method compared with conventional methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.